IGF1 and plasma cell myeloma: Emerging evidence suggests that IGF-1 and IGF-1R signaling play a pivotal role in the oncogenic transformation, growth and survival of a variety of cancers, including prostate cancer, breast cancer, colon cancer, and myeloma [23,30,31].